Enhancing Dendritic Cell Therapy in Solid Tumors with Immunomodulating Conventional Treatment

por Belderbos, Robert A., Aerts, Joachim G.J.V., Vroman, Heleen
Publicado 2019

Cellular Immunotherapy and Locoregional Administration of CAR T-Cells in Malignant Pleural Mesothelioma

por Belderbos, Robert A., Vroman, Heleen, Aerts, Joachim G. J. V.
Publicado 2020

In Response to “Intratumor Distribution of Ki-67 Antigen Beyond Labeling Index for Clinical Decision Making: A New Way of Counting”

por Belderbos, Robert A., Aerts, Joachim G.J. V., von der Thüsen, Jan H.
Publicado 2021

Nivolumab in pre-treated malignant pleural mesothelioma: real-world data from the Dutch expanded access program

por Cantini, Luca, Belderbos, Robert A., Gooijer, Cornedine J., Dumoulin, Daphne W., Cornelissen, Robin, Baart, Sara, Burgers, Jacobus A., Baas, Paul, Aerts, Joachim G. J. V.
Publicado 2020

Ki67 (MIB-1) as a Prognostic Marker for Clinical Decision Making Before Extended Pleurectomy Decortication in Malignant Pleural Mesothelioma

por Belderbos, Robert A., Maat, Alexander P.W.M., Baart, Sara J., Madsen, Eva V.E, Bogers, Ad J.J.C., Cornelissen, Robin, Aerts, Joachim G.J.V., Mahtab, Edris A.F., von der Thüsen, Jan H.
Publicado 2021

T cell receptor repertoire characteristics both before and following immunotherapy correlate with clinical response in mesothelioma

por Vroman, Heleen, Balzaretti, Giulia, Belderbos, Robert A, Klarenbeek, Paul L, van Nimwegen, Menno, Bezemer, Koen, Cornelissen, Robin, Niewold, Ilse T G, van Schaik, Barbera D, van Kampen, Antione H, Aerts, Joachim G J V, de Vries, Niek, Hendriks, Rudi W
Publicado 2020

Incidence, treatment and survival of malignant pleural and peritoneal mesothelioma: a population-based study

por van Kooten, Job P, Belderbos, Robert A, von der Thüsen, Jan H, Aarts, Mieke J, Verhoef, Cornelis, Burgers, Jacobus A, Baas, Paul, Aalbers, Arend G J, Maat, Alexander P W M, Aerts, Joachim G J V, Cornelissen, Robin, Madsen, Eva V E
Publicado 2022

OX40 agonism enhances PD-L1 checkpoint blockade by shifting the cytotoxic T cell differentiation spectrum

por van der Sluis, Tetje C., Beyrend, Guillaume, van der Gracht, Esmé T.I., Abdelaal, Tamim, Jochems, Simon P., Belderbos, Robert A., Wesselink, Thomas H., van Duikeren, Suzanne, van Haften, Floortje J., Redeker, Anke, Ouboter, Laura F., Beyranvand Nejad, Elham, Camps, Marcel, Franken, Kees L.M.C., Linssen, Margot M., Hohenstein, Peter, de Miranda, Noel F.C.C., Mei, Hailiang, Bins, Adriaan D., Haanen, John B.A.G., Aerts, Joachim G., Ossendorp, Ferry, Arens, Ramon
Publicado 2023